Atlas Trials

Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer

Clinical trial NCT01505153 · COMPLETED

Trial details

NCT number
NCT01505153
Sponsor
Gradalis, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced CancerMetastatic CancerSolid Tumors
Start date
2012-02-01
Primary completion
2017-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.